81 results on '"Mann, Graham"'
Search Results
2. The landscape of genomic structural variation in Indigenous Australians
- Author
-
Reis, Andre L. M., Rapadas, Melissa, Hammond, Jillian M., Gamaarachchi, Hasindu, Stevanovski, Igor, Ayuputeri Kumaheri, Meutia, Chintalaphani, Sanjog R., Dissanayake, Duminda S. B., Siggs, Owen M., Hewitt, Alex W., Llamas, Bastien, Brown, Alex, Baynam, Gareth, Mann, Graham J., McMorran, Brendan J., Easteal, Simon, Hermes, Azure, Jenkins, Misty R., Patel, Hardip R., and Deveson, Ira W.
- Abstract
Indigenous Australians harbour rich and unique genomic diversity. However, Aboriginal and Torres Strait Islander ancestries are historically under-represented in genomics research and almost completely missing from reference datasets1–3. Addressing this representation gap is critical, both to advance our understanding of global human genomic diversity and as a prerequisite for ensuring equitable outcomes in genomic medicine. Here we apply population-scale whole-genome long-read sequencing4to profile genomic structural variation across four remote Indigenous communities. We uncover an abundance of large insertion–deletion variants (20–49 bp; n= 136,797), structural variants (50 b–50 kb; n= 159,912) and regions of variable copy number (>50 kb; n= 156). The majority of variants are composed of tandem repeat or interspersed mobile element sequences (up to 90%) and have not been previously annotated (up to 62%). A large fraction of structural variants appear to be exclusive to Indigenous Australians (12% lower-bound estimate) and most of these are found in only a single community, underscoring the need for broad and deep sampling to achieve a comprehensive catalogue of genomic structural variation across the Australian continent. Finally, we explore short tandem repeats throughout the genome to characterize allelic diversity at 50 known disease loci5, uncover hundreds of novel repeat expansion sites within protein-coding genes, and identify unique patterns of diversity and constraint among short tandem repeat sequences. Our study sheds new light on the dimensions and dynamics of genomic structural variation within and beyond Australia.
- Published
- 2023
- Full Text
- View/download PDF
3. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices
- Author
-
Howard, Kirsten, Barratt, Alex, Mann, Graham J., and Patel, Manish I.
- Subjects
Immune system -- Testing ,Immune system -- Usage ,Immune system -- Research ,Cancer -- Diagnosis ,Cancer -- Models ,Cancer -- Research ,Prostate cancer -- Risk factors ,Prostate cancer -- Diagnosis ,Prostate cancer -- Research ,Decision-making -- Research ,Health - Published
- 2009
4. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
- Author
-
Goldstein, Alisa M., Chan, May, Harland, Mark, Hayward, Nicholas K., Demenais, Florence, Bishop, D. Timothy, Azizi, Esther, Bergman, Wilma, Bianchi-Scarra, Giovanna, Bruno, William, Calista, Donato, Albright, Lisa A. Cannon, Chaudru, Valerie, Chompret, Agnes, Cuellar, Francisco, Elder, David E., Ghiorzo, Paola, Gillanders, Elizabeth M., Gruis, Nelleke A., Hansson, Johan, Hogg, David, Holland, Elizabeth A., Kanetsky, Peter A., Kefford, Richard F., Landi, Maria Teresa, Lang, Julie, Leachman, Sancy A., MacKie, Rona M., Magnusson, Veronica, Mann, Graham J., Bishop, Julia Newton, Palmer, Jane M., Puig, Susana, Puig-Butille, Joan A., Stark, Mitchell, Tsao, Hensin, Tucker, Margaret A., Whitaker, Linda, and Yakobson, Emanuel
- Subjects
Melanoma -- Research ,Melanoma -- Risk factors ,Melanoma -- Genetic aspects ,Melanoma -- Demographic aspects ,Gene mutations -- Research ,Gene mutations -- Health aspects ,Health - Published
- 2007
5. Geographical variation in the penetrance of CDKN2A mutations for melanoma
- Author
-
Bishop, D. Timothy, Demenais, Florence, Goldstein, Alisa M., Bergman, Wilma, Newton Bishop, Julia, Bressac-de Paillerets, Brigitte, Chompret, Agnes, Ghiorzo, Paola, Gruis, Nelleke, Hansson, Johan, Harland, Mark, Hayward, Nicholas, Holland, Elizabeth A., Mann, Graham J., Mantelli, Michela, Nancarrow, Derek, Platz, Anton, and Tucker, Margaret A.
- Subjects
Melanoma -- Genetic aspects ,Gene mutations -- Analysis ,Disease susceptibility -- Causes of ,Health - Abstract
Background: Germline mutations in the CDKN2A gene, which encodes two proteins (p16INK4A and p14ARF), are the most common cause of inherited susceptibility to melanoma. We examined the penetrance of such mutations using data from eight groups from Europe, Australia and the United States that are part of The Melanoma Genetics Consortium. Methods: We analyzed 80 families with documented CDKN2A mutations and multiple cases of cutaneous melanoma. We modeled penetrance for melanoma using a logistic regression model incorporating survival analysis. Hypothesis testing was based on likelihood ratio tests. Covariates included gender, alterations in p14ARF protein, and population melanoma incidence rates. All statistical tests were two-sided. Results: The 80 analyzed families contained 402 melanoma patients, 320 of whom were tested for mutations and 291 were mutation carriers. We also tested 713 unaffected family members for mutations and 194 were carriers. Overall, CDKN2A mutation penetrance was estimated to be 0.30 (95% confidence interval (CI) = 0.12 to 0.62) by age 50 years and 0.67 (95% CI = 0.31 to 0.96) by age 80 years. Penetrance was not statistically significantly modified by gender or by whether the CDKN2A mutation altered p14ARF protein. However, there was a statistically significant effect of residing in a location with a high population incidence rate of melanoma (P = .003). By age 50 years CDKN2A mutation penetrance reached 0.13 in Europe, 0.50 in the United States, and 0.32 in Australia; by age 80 years it was 0.58 in Europe, 0.76 in the United States, and 0.91 in Australia. Conclusions: This study, which gives the most informed estimates of CDKN2A mutation penetrance available, indicates that the penetrance varies with melanoma population incidence rates. Thus, the same factors that affect population incidence of melanoma may also mediate CDKN2A penetrance. [J Natl Cancer Inst 2002;94:894-903]
- Published
- 2002
6. Dominant negative ATM mutations in breast cancer families
- Author
-
Chenevix-Trench, Georgia, Spurdle, Amanda B., Gatei, Magtouf, Kelly, Helena, Marsh, Anna, Chen, Xiaoqing, Donn, Karen, Cummings, Margaret, Nyholt, Dale, Jenkins, Mark A., Scott, Clare, Pupo, Gulietta M., Dork, Thilo, Bendix, Regina, Kirk, Judy, Tucker, Katherine, McCredie, Margaret R.E., Hopper, John L., Sambrook, Joseph, Mann, Graham J., and Khanna, Kum Kum
- Subjects
Gene mutations -- Physiological aspects ,Breast cancer -- Genetic aspects ,Health - Abstract
Background: The ATM gene encoding a putative protein kinase is mutated in ataxia-telangiectasia (A-T), an autosomal recessive disorder with a predisposition for cancer. Studies of A-T families suggest that female heterozygotes have an increased risk of breast cancer compared with non-carriers. However, neither linkage analyses nor mutation studies have provided supporting evidence for a role of ATM in breast cancer predisposition. Nevertheless, two recurrent ATM mutations, T7271G and IVS10-6T[right arrow]G, reportedly increase the risk of breast cancer. We examined these two ATM mutations in a population-based, case--control series of breast cancer families and multiple-case breast cancer families. Methods: Five hundred twenty-five or 262 case patients with breast cancer and 381 or 68 control subjects, respectively, were genotyped for the T7271G and IVS10-6T[right arrow]G ATM mutations, as were index patients from 76 non-BRCA1/2 multiple-case breast cancer families. Linkage and penetrance were analyzed. ATM protein expression and kinase activity were analyzed in lymphoblastoid cell lines from mutation carriers. All statistical tests were two-sided. Results: In case and control subjects unselected for family history of breast cancer, one case patient had the T7271G mutation, and none had the IVS10-6T [right arrow]G mutation. In three multiple-case families, one of these two mutations segregated with breast cancer. The estimated average penetrance of the mutations was 60% (95% confidence interval [CI] = 32% to 90%) to age 70 years, equivalent to a 15.7-fold (95% CI = 6.4-fold to 38.0-fold) increased relative risk compared with that of the general population. Expression and activity analyses of ATM in heterozygous cell lines indicated that both mutations are dominant negative. Conclusion: At least two ATM mutations are associated with a sufficiently high risk of breast cancer to be found in multiple-case breast cancer families. Full mutation analysis of the ATM gene in such families could help clarify the role of ATM in breast cancer susceptibility. [J Natl Cancer Inst 2002;94:205-15]
- Published
- 2002
7. Anatomic position determines oncogenic specificity in melanoma
- Author
-
Weiss, Joshua M., Hunter, Miranda V., Cruz, Nelly M., Baggiolini, Arianna, Tagore, Mohita, Ma, Yilun, Misale, Sandra, Marasco, Michelangelo, Simon-Vermot, Theresa, Campbell, Nathaniel R., Newell, Felicity, Wilmott, James S., Johansson, Peter A., Thompson, John F., Long, Georgina V., Pearson, John V., Mann, Graham J., Scolyer, Richard A., Waddell, Nicola, Montal, Emily D., Huang, Ting-Hsiang, Jonsson, Philip, Donoghue, Mark T. A., Harris, Christopher C., Taylor, Barry S., Xu, Tianhao, Chaligné, Ronan, Shliaha, Pavel V., Hendrickson, Ronald, Jungbluth, Achim A., Lezcano, Cecilia, Koche, Richard, Studer, Lorenz, Ariyan, Charlotte E., Solit, David B., Wolchok, Jedd D., Merghoub, Taha, Rosen, Neal, Hayward, Nicholas K., and White, Richard M.
- Abstract
Oncogenic alterations to DNA are not transforming in all cellular contexts1,2. This may be due to pre-existing transcriptional programmes in the cell of origin. Here we define anatomic position as a major determinant of why cells respond to specific oncogenes. Cutaneous melanoma arises throughout the body, whereas the acral subtype arises on the palms of the hands, soles of the feet or under the nails3. We sequenced the DNA of cutaneous and acral melanomas from a large cohort of human patients and found a specific enrichment for BRAFmutations in cutaneous melanoma and enrichment for CRKLamplifications in acral melanoma. We modelled these changes in transgenic zebrafish models and found that CRKL-driven tumours formed predominantly in the fins of the fish. The fins are the evolutionary precursors to tetrapod limbs, indicating that melanocytes in these acral locations may be uniquely susceptible to CRKL. RNA profiling of these fin and limb melanocytes, when compared with body melanocytes, revealed a positional identity gene programme typified by posterior HOX13genes. This positional gene programme synergized with CRKLto amplify insulin-like growth factor (IGF) signalling and drive tumours at acral sites. Abrogation of this CRKL-driven programme eliminated the anatomic specificity of acral melanoma. These data suggest that the anatomic position of the cell of origin endows it with a unique transcriptional state that makes it susceptible to only certain oncogenic insults.
- Published
- 2022
- Full Text
- View/download PDF
8. Association Between Melanoma Detected During Routine Skin Checks and Mortality
- Author
-
Watts, Caroline G., McLoughlin, Kirstie, Goumas, Chris, van Kemenade, Cathelijne H., Aitken, Joanne F., Soyer, H. Peter, Fernandez Peñas, Pablo, Guitera, Pascale, Scolyer, Richard A., Morton, Rachael L., Menzies, Scott W., Caruana, Michael, Kang, Yoon Jung, Mann, Graham J., Chakera, Annette H., Madronio, Christine M., Armstrong, Bruce K., Thompson, John F., and Cust, Anne E.
- Abstract
IMPORTANCE: Early melanoma diagnosis is associated with better health outcomes, but there is insufficient evidence that screening, such as having routine skin checks, reduces mortality. OBJECTIVE: To assess melanoma-specific and all-cause mortality associated with melanomas detected through routine skin checks, incidentally or patient detected. A secondary aim was to examine patient, sociodemographic, and clinicopathologic factors associated with different modes of melanoma detection. DESIGN, SETTING, AND PARTICIPANTS: This prospective, population-based, cohort study included patients in New South Wales, Australia, who were diagnosed with melanoma over 1 year from October 23, 2006, to October 22, 2007, in the Melanoma Patterns of Care Study and followed up until 2018 (mean [SD] length of follow-up, 11.9 [0.3] years) by using linked mortality and cancer registry data. All patients who had invasive melanomas recorded at the cancer registry were eligible for the study, but the number of in situ melanomas was capped. The treating doctors recorded details of melanoma detection and patient and clinical characteristics in a baseline questionnaire. Histopathologic variables were obtained from pathology reports. Of 3932 recorded melanomas, data were available and analyzed for 2452 (62%; 1 per patient) with primary in situ (n = 291) or invasive (n = 2161) cutaneous melanoma. Data were analyzed from March 2020 to January 2021. MAIN OUTCOMES AND MEASURES: Melanoma-specific mortality and all-cause mortality. RESULTS: A total of 2452 patients were included in the analyses. The median age at diagnosis was 65 years (range, 16-98 years), and 1502 patients (61%) were men. A total of 858 patients (35%) had their melanoma detected during a routine skin check, 1148 (47%) self-detected their melanoma, 293 (12%) had their melanoma discovered incidentally when checking another skin lesion, and 153 (6%) reported “other” presentation. Routine skin-check detection of invasive melanomas was associated with 59% lower melanoma-specific mortality (subhazard ratio, 0.41; 95% CI, 0.28-0.60; P < .001) and 36% lower all-cause mortality (hazard ratio, 0.64; 95% CI, 0.54-0.76; P < .001), adjusted for age and sex, compared with patient-detected melanomas. After adjusting for prognostic factors including ulceration and mitotic rate, the associations were 0.68 (95% CI, 0.44-1.03; P = .13), and 0.75 (95% CI, 0.63-0.90; P = .006), respectively. Factors associated with higher odds of routine skin-check melanoma detection included being male (female vs male, odds ratio [OR], 0.73; 95% CI, 0.60-0.89; P = .003), having previous melanoma (vs none, OR, 2.36; 95% CI, 1.77-3.15; P < .001), having many moles (vs not, OR, 1.39; 95% CI, 1.10-1.77; P = .02), being 50 years or older (eg, 50-59 years vs <40 years, OR, 2.89; 95% CI, 1.92-4.34; P < .001), and living in nonremote areas (eg, remote or very remote vs major cities, OR, 0.23; 95% CI, 0.05-1.04; P = .003). CONCLUSIONS AND RELEVANCE: In this cohort study, melanomas diagnosed through routine skin checks were associated with significantly lower all-cause mortality, but not melanoma-specific mortality, after adjustment for patient, sociodemographic, and clinicopathologic factors.
- Published
- 2021
- Full Text
- View/download PDF
9. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial
- Author
-
Smit, Amelia K., Allen, Martin, Beswick, Brooke, Butow, Phyllis, Dawkins, Hugh, Dobbinson, Suzanne J., Dunlop, Kate L., Espinoza, David, Fenton, Georgina, Kanetsky, Peter A., Keogh, Louise, Kimlin, Michael G., Kirk, Judy, Law, Matthew H., Lo, Serigne, Low, Cynthia, Mann, Graham J., Reyes-Marcelino, Gillian, Morton, Rachael L., Newson, Ainsley J., Savard, Jacqueline, Trevena, Lyndal, Wordsworth, Sarah, and Cust, Anne E.
- Abstract
We evaluated the impact of personal melanoma genomic risk information on sun-related behaviors and psychological outcomes.
- Published
- 2021
- Full Text
- View/download PDF
10. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance
- Author
-
Guitera, Pascale, Menzies, Scott W., Coates, Elliot, Azzi, Anthony, Fernandez-Penas, Pablo, Lilleyman, Alister, Badcock, Caro, Schmid, Helen, Watts, Caroline G., Collgros, Helena, Liu, Rose, van Kemenade, Cathelijne, Mann, Graham J., and Cust, Anne E.
- Abstract
IMPORTANCE: A previous single-center study observed fewer excisions, lower health care costs, thinner melanomas, and better quality of life when surveillance of high-risk patients was conducted in a melanoma dermatology clinic with a structured surveillance protocol involving full-body examinations every 6 months aided by total-body photography (TBP) and sequential digital dermoscopy imaging (SDDI). OBJECTIVE: To examine longer-term sustainability and expansion of the surveillance program to numerous practices, including a primary care skin cancer clinic setting. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study recruited 593 participants assessed from 2012 to 2018 as having very high risk of melanoma, with a median of 2.9 years of follow-up (interquartile range, 1.9-3.3 years), from 4 melanoma high-risk clinics (3 dermatology clinics and 1 primary care skin cancer clinic) in New South Wales, Australia. Data analyses were conducted from February to September 2020. EXPOSURES: Six-month full-body examination with the aid of TBP and SDDI. For equivocal lesions, the clinician performed SDDI at 3 or 6 months. MAIN OUTCOMES AND MEASURES: All suspect monitored or excised lesions were recorded, and pathology reports obtained. Outcomes included the incidence and characteristics of new lesions and the association of diagnostic aids with rates of new melanoma detection. RESULTS: Among 593 participants, 340 (57.3%) were men, and the median age at baseline was 58 years (interquartile range, 47-66 years). There were 1513 lesions excised during follow-up, including 171 primary melanomas. The overall benign to malignant excision ratio, including keratinocyte carcinomas, was 0.8:1.0; the benign melanocytic to melanoma excision ratio was 2.4:1.0; and the melanoma in situ to invasive melanoma ratio was 2.2:1.0. The excision ratios were similar across the 4 centers. The risk of developing a new melanoma was 9.0% annually in the first 2 years and increased with time, particularly for those with multiple primary melanomas. The thicker melanomas (>1-mm Breslow thickness; 7 of 171 melanomas [4.1%]) were mostly desmoplastic or nodular (4 of 7), self-detected (2 of 7), or clinician detected without the aid of TBP (3 of 7). Overall, new melanomas were most likely to be detected by a clinician with the aid of TBP (54 of 171 [31.6%]) followed by digital dermoscopy monitoring (50 of 171 [29.2%]). CONCLUSIONS AND RELEVANCE: The structured surveillance program for high-risk patients may be implemented at a larger scale given the present cohort study findings suggesting the sustainability and replication of results in numerous settings, including a primary care skin cancer clinic.
- Published
- 2021
- Full Text
- View/download PDF
11. Antarctic Vortex Dehydration in 2023 as a Substantial Removal Pathway for Hunga Tonga‐Hunga Ha'apai Water Vapor
- Author
-
Zhou, Xin, Dhomse, Sandip S., Feng, Wuhu, Mann, Graham, Heddell, Saffron, Pumphrey, Hugh, Kerridge, Brian J., Latter, Barry, Siddans, Richard, Ventress, Lucy, Querel, Richard, Smale, Penny, Asher, Elizabeth, Hall, Emrys G., Bekki, Slimane, and Chipperfield, Martyn P.
- Abstract
The January 2022 eruption of Hunga Tonga‐Hunga Ha'apai (HTHH) injected a huge amount (∼150 Tg) of water vapor (H2O) into the stratosphere, along with small amount of SO2. An off‐line 3‐D chemical transport model (CTM) successfully reproduces the spread of the injected H2O through October 2023 as observed by the Microwave Limb Sounder. Dehydration in the 2023 Antarctic polar vortex caused the first substantial (∼20 Tg) removal of HTHH H2O from the stratosphere. The CTM indicates that this process will dominate removal of HTHH H2O for the coming years, giving an overall e‐folding timescale of 4 years; around 25 Tg of the injected H2O is predicted to still remain in the stratosphere by 2030. Following relatively low Antarctic column ozone in midwinter 2023 due to transport effects, additional springtime depletion due to H2O‐related chemistry was small and maximized at the vortex edge (10 DU in column). Around 150 Tg (150 million tons) of water vapor was injected into the stratosphere during the eruption of Hunga Tonga‐Hunga Ha'apai. Water vapor is a greenhouse gas and this increase is expected to have a warming effect in the troposphere, as well causing perturbations in stratospheric chemistry and aerosols. We use an atmospheric model to study the residence time of this excess water vapor and its impact on the recent Antarctic ozone hole. The model performance is evaluated by comparison with satellite measurements. Wintertime dehydration in the Antarctic stratosphere in 2023 is found to be an important mechanism for removal of the volcanic water from the stratosphere. However, the overall removal rate is predicted to be slow; around 25 Tg (17%) is still present in 2030. The direct impact of the excess water vapor on ozone via chemical processes in the Antarctic ozone hole in 2023 is small. Antarctic dehydration is a major removal pathway of stratospheric H2O injected from Hunga Tonga‐Hunga Ha'apai (HTHH) eruptionHTHH H2O caused small (up to 10 DU) additional chemical ozone depletion in 2023 Antarctic springModel indicates e‐folding timescale of 4 years for removal of HTHH H2O from stratosphere Antarctic dehydration is a major removal pathway of stratospheric H2O injected from Hunga Tonga‐Hunga Ha'apai (HTHH) eruption HTHH H2O caused small (up to 10 DU) additional chemical ozone depletion in 2023 Antarctic spring Model indicates e‐folding timescale of 4 years for removal of HTHH H2O from stratosphere
- Published
- 2024
- Full Text
- View/download PDF
12. Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies
- Author
-
Cust, Anne E., Drummond, Martin, Kanetsky, Peter A., Mann, Graham J., Cust, Anne E., Schmid, Helen, Hopper, John L., Aitken, Joanne F., Armstrong, Bruce K., Giles, Graham G., Holland, Elizabeth, Kefford, Richard F., Jenkins, Mark A., Newton Bishop, Julia A., Affleck, Paul, Barrett, Jennifer H., Bishop, D. Timothy, Harrison, Jane, Iles, Mark M., Randerson-Moor, Juliette, Harland, Mark, Taylor, John C., Whittaker, Linda, Kukalizch, Kairen, Leake, Susan, Karpavicius, Birute, Haynes, Sue, Mack, Tricia, Chan, May, Taylor, Yvonne, Davies, John, King, Paul, Goldstein, Alisa M., Barrett, Jennifer H., MacGregor, Stuart, Law, Matthew H., Iles, Mark M., Bui, Minh, Hopper, John L., Brossard, Myriam, Demenais, Florence, Taylor, John C., Hoggart, Clive, Brown, Kevin M., Landi, Maria Teresa, Newton-Bishop, Julia A., Mann, Graham J., and Bishop, D. Timothy
- Abstract
It is unclear to what degree genomic and traditional (phenotypic and environmental) risk factors overlap in their prediction of melanoma risk. We evaluated the incremental contribution of common genomic variants (in pigmentation, nevus, and other pathways) and their overlap with traditional risk factors, using data from two population-based case-control studies from Australia (n = 1,035) and the United Kingdom (n = 1,460) that used the same questionnaires. Polygenic risk scores were derived from 21 gene regions associated with melanoma and odds ratios from published meta-analyses. Logistic regression models were adjusted for age, sex, center, and ancestry. Adding the polygenic risk score to a model with traditional risk factors increased the area under the receiver operating characteristic curve (AUC) by 2.3% (P = 0.003) for Australia and by 2.8% (P = 0.002) for Leeds. Gene variants in the pigmentation pathway, particularly MC1R, were responsible for most of the incremental improvement. In a cross-tabulation of polygenic by traditional tertile risk scores, 59% (Australia) and 49% (Leeds) of participants were categorized in the same (concordant) tertile. Of participants with low traditional risk, 9% (Australia) and 21% (Leeds) had high polygenic risk. Testing of genomic variants can identify people who are susceptible to melanoma despite not having a traditional phenotypic risk profile.
- Published
- 2018
- Full Text
- View/download PDF
13. Whole-Genome-Sequenzierung von Schleimhautmelanomen zeigt diverse Treiber und therapeutische Targets auf
- Author
-
Newell, Felicity, Kong, Yan, Wilmott, James S., Johansson, Peter A., Ferguson, Peter M., Cui, Chuanliang, Li, Zhongwu, Kazakoff, Stephen H., Burke, Hazel, Dodds, Tristan J., Patch, Ann-Marie, Nones, Katia, Tembe, Varsha, Shang, Ping, van der Weyden, Louise, Wong, Kim, Holmes, Oliver, Lo, Serigne, Leonard, Conrad, Wood, Scott, Xu, Qinying, Rawson, Robert V., Mukhopadhyay, Pamela, Dummer, Reinhard, Levesque, Mitchell P., Jönsson, Göran, Wang, Xuan, Yeh, Iwei, Wu, Hong, Joseph, Nancy, Bastian, Boris C., Long, Georgina V., Spillane, Andrew J., Shannon, Kerwin F., Thompson, John F., Saw, Robyn P.M., Adams, David J., Si, Lu, Pearson, John V., Hayward, Nicholas K., Waddell, Nicola, Mann, Graham J., Guo, Jun, and Scolyer, Richard A.
- Abstract
Das Wissen über die genetischen Treiber und therapeutischen Zielstrukturen von Melanomen der Schleimhäute ist bisher lückenhaft, weil nur wenig umfassende Daten zu den Mutationen bei dieser seltenen Tumorart vorliegen. Um die genomische Landschaft des mukosalen Melanoms besser zu verstehen, beschreiben wir hier die Analyse von 67 Tumoren mittels Whole-Genome-Sequenzierung nebst Validierung von Treibermutationen durch Whole-Exome-Sequenzierung von 45 Tumoren. Die Tumoren zeigten eine geringe Punktmutationslast und eine hohe Zahl von Strukturvarianten, einschließlich rekurrenter Rearrangements im Bereich von TERT, CDK4und MDM2. Signifikant mutierte Gene sind NRAS, BRAF, NF1, KIT, SF3B1, TP53, SPRED1, ATRX, HLA-Aund CHD8. SF3B1-Mutationen kamen mit erhöhter Häufigkeit in Melanomen des weiblichen Genitaltrakts und der Anorektalregion vor, und CTNNB1-Mutationen deuten auf den Beitrag einer gestörten WNT-Signaltransduktion zur Entstehung eines Teils der Schleimhautmelanome hin. TERT-Aberrationen und ATRX-Mutationen sind mit Veränderungen der Telomerlängen assoziiert. Die Mutationsprofile eines Großteils der Schleimhautmelanome deuten auf eine mögliche Empfindlichkeit gegenüber CDK4/6- und/oder MEK-Inhibitoren hin.
- Published
- 2020
- Full Text
- View/download PDF
14. Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
- Author
-
Landi, Maria Teresa, Bishop, D. Timothy, MacGregor, Stuart, Machiela, Mitchell J., Stratigos, Alexander J., Ghiorzo, Paola, Brossard, Myriam, Calista, Donato, Choi, Jiyeon, Fargnoli, Maria Concetta, Zhang, Tongwu, Rodolfo, Monica, Trower, Adam J., Menin, Chiara, Martinez, Jacobo, Hadjisavvas, Andreas, Song, Lei, Stefanaki, Irene, Scolyer, Richard, Yang, Rose, Goldstein, Alisa M., Potrony, Miriam, Kypreou, Katerina P., Pastorino, Lorenza, Queirolo, Paola, Pellegrini, Cristina, Cattaneo, Laura, Zawistowski, Matthew, Gimenez-Xavier, Pol, Rodriguez, Arantxa, Elefanti, Lisa, Manoukian, Siranoush, Rivoltini, Licia, Smith, Blair H., Loizidou, Maria A., Del Regno, Laura, Massi, Daniela, Mandala, Mario, Khosrotehrani, Kiarash, Akslen, Lars A., Amos, Christopher I., Andresen, Per A., Avril, Marie-Françoise, Azizi, Esther, Soyer, H. Peter, Bataille, Veronique, Dalmasso, Bruna, Bowdler, Lisa M., Burdon, Kathryn P., Chen, Wei V., Codd, Veryan, Craig, Jamie E., Dębniak, Tadeusz, Falchi, Mario, Fang, Shenying, Friedman, Eitan, Simi, Sarah, Galan, Pilar, Garcia-Casado, Zaida, Gillanders, Elizabeth M., Gordon, Scott, Green, Adele, Gruis, Nelleke A., Hansson, Johan, Harland, Mark, Harris, Jessica, Helsing, Per, Henders, Anjali, Hočevar, Marko, Höiom, Veronica, Hunter, David, Ingvar, Christian, Kumar, Rajiv, Lang, Julie, Lathrop, G. Mark, Lee, Jeffrey E., Li, Xin, Lubiński, Jan, Mackie, Rona M., Malt, Maryrose, Malvehy, Josep, McAloney, Kerrie, Mohamdi, Hamida, Molven, Anders, Moses, Eric K., Neale, Rachel E., Novaković, Srdjan, Nyholt, Dale R., Olsson, Håkan, Orr, Nicholas, Fritsche, Lars G., Puig-Butille, Joan Anton, Qureshi, Abrar A., Radford-Smith, Graham L., Randerson-Moor, Juliette, Requena, Celia, Rowe, Casey, Samani, Nilesh J., Sanna, Marianna, Schadendorf, Dirk, Schulze, Hans-Joachim, Simms, Lisa A., Smithers, Mark, Song, Fengju, Swerdlow, Anthony J., van der Stoep, Nienke, Kukutsch, Nicole A., Visconti, Alessia, Wallace, Leanne, Ward, Sarah V., Wheeler, Lawrie, Sturm, Richard A., Hutchinson, Amy, Jones, Kristine, Malasky, Michael, Vogt, Aurelie, Zhou, Weiyin, Pooley, Karen A., Elder, David E., Han, Jiali, Hicks, Belynda, Hayward, Nicholas K., Kanetsky, Peter A., Brummett, Chad, Montgomery, Grant W., Olsen, Catherine M., Hayward, Caroline, Dunning, Alison M., Martin, Nicholas G., Evangelou, Evangelos, Mann, Graham J., Long, Georgina, Pharoah, Paul D. P., Easton, Douglas F., Barrett, Jennifer H., Cust, Anne E., Abecasis, Goncalo, Duffy, David L., Whiteman, David C., Gogas, Helen, De Nicolo, Arcangela, Tucker, Margaret A., Newton-Bishop, Julia A., Peris, Ketty, Chanock, Stephen J., Demenais, Florence, Brown, Kevin M., Puig, Susana, Nagore, Eduardo, Shi, Jianxin, Iles, Mark M., and Law, Matthew H.
- Abstract
Most genetic susceptibility to cutaneous melanoma remains to be discovered. Meta-analysis genome-wide association study (GWAS) of 36,760 cases of melanoma (67% newly genotyped) and 375,188 controls identified 54 significant (P< 5 × 10−8) loci with 68 independent single nucleotide polymorphisms. Analysis of risk estimates across geographical regions and host factors suggests the acral melanoma subtype is uniquely unrelated to pigmentation. Combining this meta-analysis with GWAS of nevus count and hair color, and transcriptome association approaches, uncovered 31 potential secondary loci for a total of 85 cutaneous melanoma susceptibility loci. These findings provide insights into cutaneous melanoma genetic architecture, reinforcing the importance of nevogenesis, pigmentation and telomere maintenance, together with identifying potential new pathways for cutaneous melanoma pathogenesis.
- Published
- 2020
- Full Text
- View/download PDF
15. Variation in initial biopsy technique for primary melanoma diagnosis: a population-based cohort study in New South Wales, Australia
- Author
-
Dempsey, Kathy, Ho, Genevieve, Lo, Serigne N., McKeown, Janet, Watts, Caroline G., Cust, Anne E., Guitera, Pascale, Scolyer, Richard A., Thompson, John F., Morton, Rachael L., Menzies, Scott, Madronio, Christine, and Mann, Graham
- Abstract
Factors associated with non-adherence to guideline-recommended complete excision of suspicious cutaneous lesions are unclear.
- Published
- 2024
- Full Text
- View/download PDF
16. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
- Author
-
Law, Chi Kin, Cust, Anne E., Smit, Amelia K., Trevena, Lyndal, Fernandez-Penas, Pablo, Nieweg, Omgo E., Menzies, Alexander M., Wordsworth, Sarah, Morton, Rachael L., Newson, Ainsley J., Morton, Rachael L., Kimlin, Michael, Keogh, Louise, Law, Matthew, Kirk, Judy, Dobbinson, Suzanne J., Kanetsky, Peter, Mann, Graham, Dawkins, Hugh, Savard, Jacqueline, Dunlop, Kate, Trevena, Lyndal, Jenkins, Mark, Allen, Martin, Butow, Phyllis, Wordsworth, Sarah, Lo, Serigne, Low, Cynthia, Smit, Amelia K., Espinoza, David, and Cust, Anne E.
- Abstract
Evidence indicates that a melanoma prevention program using personalized genomic risk provision and genetic counseling can affect prevention behaviors, including reducing sunburns in adults with no melanoma history. This analysis evaluated its longer-term cost-effectiveness from an Australian health system perspective.
- Published
- 2023
- Full Text
- View/download PDF
17. Evaluation of the contribution of germline variants in BRCA1and BRCA2to uveal and cutaneous melanoma
- Author
-
Johansson, Peter A., Nathan, Vaishnavi, Bourke, Lauren M., Palmer, Jane M., Zhang, Tongwu, Symmons, Judith, Howlie, Madeleine, Patch, Ann-Marie, Read, Jazlyn, Holland, Elizabeth A., Schmid, Helen, Warrier, Sunil, Glasson, William, Höiom, Veronica, Wadt, Karin, Jönsson, Göran, Olsson, Håkan, Ingvar, Christian, Mann, Graham, Brown, Kevin M., Hayward, Nicholas K., and Pritchard, Antonia L.
- Abstract
Supplemental Digital Content is available in the text.Germline mutations of BRCA1and BRCA2predispose individuals to a high risk of breast and ovarian cancer, and elevated risk of other cancers, including those of the pancreas and prostate. BRCA2mutation carriers may have increased risk of uveal melanoma (UM) and cutaneous melanoma (CM), but associations with these cancers in BRCA1mutation carriers have been mixed. Here, we further assessed whether UM and CM are associated with BRCA1or BRCA2by assessing the presence, segregation and reported/predicted pathogenicity of rare germline mutations (variant allele frequency < 0.01) in families with multiple members affected by these cancers. Whole-genome or exome sequencing was performed on 160 CM and/or UM families from Australia, the Netherlands, Denmark and Sweden. Between one and five cases were sequenced from each family, totalling 307 individuals. Sanger sequencing was performed to validate BRCA1and BRCA2germline variants and to assess carrier status in other available family members. A nonsense and a frameshift mutation were identified in BRCA1, both resulting in premature truncation of the protein (the first at p.Q516 and the second at codon 91, after the introduction of seven amino acids due to a frameshift deletion). These variants co-segregated with CM in individuals who consented for testing and were present in individuals with pancreatic, prostate and breast cancer in the respective families. In addition, 33 rare missense mutations (variant allele frequency ranging from 0.00782 to 0.000001 in the aggregated ExAC data) were identified in 34 families. Examining the previously reported evidence of functional consequence of these variants revealed all had been classified as either benign or of unknown consequence. Seeking further evidence of an association between BRCA1variants and melanoma, we examined two whole-genome/exome sequenced collections of sporadic CM patients (total N= 763). We identified one individual with a deleterious BRCA1variant, however, this allele was lost (with the wild-type allele remaining) in the corresponding CM, indicating that defective BRCA1was not a driver of tumorigenesis in this instance. Although this is the first time that deleterious BRCA1mutations have been described in high-density CM families, we conclude that there is an insufficient burden of evidence to state that the increased familial CM or UM susceptibility is because of these variants. In addition, in conjunction with other studies, we conclude that the previously described association between BRCA2mutations and UM susceptibility represents a rare source of increased risk.
- Published
- 2019
- Full Text
- View/download PDF
18. Molecular Genomic Profiling of Melanocytic Nevi
- Author
-
Colebatch, Andrew J., Ferguson, Peter, Newell, Felicity, Kazakoff, Stephen H., Witkowski, Tom, Dobrovic, Alexander, Johansson, Peter A., Saw, Robyn P.M., Stretch, Jonathan R., McArthur, Grant A., Long, Georgina V., Thompson, John F., Pearson, John V., Mann, Graham J., Hayward, Nicholas K., Waddell, Nicola, Scolyer, Richard A., and Wilmott, James S.
- Abstract
The benign melanocytic nevus is the most common tumor in humans and rarely transforms into cutaneous melanoma. Elucidation of the nevus genome is required to better understand the molecular steps of progression to melanoma. We performed whole genome sequencing on a series of 14 benign melanocytic nevi consisting of both congenital and acquired types. All nevi had driver mutations in the MAPK signaling pathway, either BRAFV600E or NRASQ61R/L. No additional definite driver mutations were identified. Somatic mutations in nevi with higher mutation loads showed a predominance of mutational signatures 7a and 7b, consistent with UVR exposure, whereas nevi with lower mutation loads (including all three congenital nevi) had a predominance of the ubiquitous signatures 1 and 5. Two nevi had mutations in promoter regions predicted to bind E26 transformation-specific family transcription factors, as well as subclonal mutations in the TERTpromoter. This paper presents whole genome data from melanocytic nevi. We confirm that UVR is involved in the etiology of a subset of nevi. This study also establishes that TERTpromoter mutations are present in morphologically benign skin nevi in subclonal populations, which has implications regarding the interpretation of this emerging biomarker in sensitive assays.
- Published
- 2019
- Full Text
- View/download PDF
19. Exploring How Eruption Source Parameters Affect Volcanic Radiative Forcing Using Statistical Emulation
- Author
-
Marshall, Lauren, Johnson, Jill S., Mann, Graham W., Lee, Lindsay, Dhomse, Sandip S., Regayre, Leighton, Yoshioka, Masaru, Carslaw, Ken S., and Schmidt, Anja
- Abstract
The radiative forcing caused by a volcanic eruption is dependent on several eruption source parameters such as the mass of sulfur dioxide (SO2) emitted, the eruption column height, and the eruption latitude. General circulation models with prognostic aerosol and chemistry schemes can be used to investigate how each parameter influences the volcanic forcing. However, the range of multidimensional parameter space that can be explored is restricted because such simulations are computationally expensive. Here we use statistical emulation to explore the radiative impact of eruptions over a wide covarying range of SO2emission magnitudes, injection heights, and eruption latitudes based on only 30 simulations. We use the emulators to build response surfaces to visualize and predict the sulfate aerosol e‐folding decay time, the stratospheric aerosol optical depth, and net radiative forcing of thousands of different eruptions. We find that the volcanic stratospheric aerosol optical depth and net radiative forcing are primarily determined by the mass of SO2emitted, but eruption latitude is the most important parameter in determining the sulfate aerosol e‐folding decay time. The response surfaces reveal joint effects of the eruption source parameters in influencing the net radiative forcing, such as a stronger influence of injection height for tropical eruptions than high‐latitude eruptions. We also demonstrate how the emulated response surfaces can be used to find all combinations of eruption source parameters that produce a particular volcanic response, often revealing multiple solutions. We demonstrate the feasibility and value of using statistical emulation to quantify the radiative impact of volcanic eruptionsEmulated response surfaces illustrate the dependencies of model output such as net radiative forcing on eruption source parametersEmulated response surfaces can also be used to constrain the eruption source parameters for a particular volcanic response
- Published
- 2019
- Full Text
- View/download PDF
20. Forest Gate PARKWAY.
- Author
-
MANN, GRAHAM
- Subjects
MINIATURE railroads ,MODEL railroads ,LOCOMOTIVE models - Abstract
A personal narrative is presented which explores the author's experience in doing business of a railway model shop.
- Published
- 2019
21. The Influence of Internal Climate Variability on Stratospheric Water Vapor Increases After Large‐Magnitude Explosive Tropical Volcanic Eruptions
- Author
-
Zhou, Xin, Mann, Graham W., Feng, Wuhu, Dhomse, Sandip S., and Chipperfield, Martyn P.
- Abstract
Substantial and prolonged enhancements in stratospheric water vapor (SWV) have occurred after large‐magnitude explosive tropical volcanic eruptions, with modified tropopause entry caused by aerosol‐absorptive heating. Here, we analyze the timing and longevity of heating‐driven post‐eruption SWV changes within CMIP6‐VolMIP short‐term climate‐response experiments with the UK Earth System Model (UKESM1). We find aerosol‐absorptive heating causes peak SWV increases of 17% (∼1 ppmv) and 10% (0.5 ppmv) at 100 and 50 hPa, at ∼18 and ∼23 months after a Pinatubo‐like eruption, respectively. We track the temperature response in the tropical lower stratosphere and identify the main SWV increase occurs only after the descending aerosol heating reaches the tropopause, suggesting a key role for aerosol microphysical processes (sedimentation rate). We explore how El Niño–Southern Oscillation variability modulates this effect. Post‐eruption SWV increases are ∼80% stronger for the La Nina phase compared to the ensemble mean. Tropical upwelling strongly mediates this effect. Strong volcanic eruptions, such as the 1991 eruption of Mt Pinatubo, inject a large amount of SO2directly into the stratosphere, thereby enhancing the stratospheric aerosol layer and causing a short‐term climatic perturbation. Another substantial part of the climatic influence is the change in stratospheric water vapor (SWV), which affects the chemical processes and the radiative budget of the atmosphere. Along with near‐instantaneous injection of water vapor into the stratosphere, volcanic eruptions can indirectly enhance the entry of water vapor into the stratosphere through aerosol‐induced tropopause heating. This work analyses Earth system model experiments designed to explore how volcanic impacts combine with internal climate variability. We find that peak SWV entry mixing ratios occur only within the second post‐eruption year, consistent with the substantially lagged timing of SWV increase seen in post‐Pinatubo satellite measurements. This analysis provides a new perspective on the temporal evolution of the observed post‐Pinatubo SWV increase and an improved quantification of its impacts. Aerosol‐induced absorptive‐heating increases stratospheric water vapor (SWV) by up to 17% at 18 months post‐eruption in a Pinatubo‐like experimentAnalyzing simulations by El Niño–Southern Oscillation (ENSO) variability show an 80% larger peak SWV increase occurs if an eruption is followed by a La Niña phaseThe timing of peak SWV increase occurs when volcanic‐aerosol‐induced heating reaches the tropopause, with ENSO modulation of tropical upwelling Aerosol‐induced absorptive‐heating increases stratospheric water vapor (SWV) by up to 17% at 18 months post‐eruption in a Pinatubo‐like experiment Analyzing simulations by El Niño–Southern Oscillation (ENSO) variability show an 80% larger peak SWV increase occurs if an eruption is followed by a La Niña phase The timing of peak SWV increase occurs when volcanic‐aerosol‐induced heating reaches the tropopause, with ENSO modulation of tropical upwelling
- Published
- 2023
- Full Text
- View/download PDF
22. Sunscreen Use and Melanoma Risk Among Young Australian Adults
- Author
-
Watts, Caroline G., Drummond, Martin, Goumas, Chris, Schmid, Helen, Armstrong, Bruce K., Aitken, Joanne F., Jenkins, Mark A., Giles, Graham G., Hopper, John L., Mann, Graham J., and Cust, Anne E.
- Abstract
IMPORTANCE: There are limited data among young adults on sunscreen use during childhood and adulthood and on the association of sunscreen use with melanoma risk. OBJECTIVE: To assess correlates of early-life sunscreen use and the association between sunscreen use and risk of cutaneous melanoma before age 40 years. DESIGN, SETTING, AND PARTICIPANTS: This population-based, case-control family study analyzed Australian Melanoma Family Study data for persons with questionnaire data on sunscreen use collected by interview from 2001 to 2005 across 3 states in Australia, representing two-thirds of the country’s population. Case participants (aged 18-39 years) had confirmed first primary melanoma. Siblings of case participants were included, and case participants without a sibling control were excluded. Unrelated controls (aged 18-44 years) were recruited from the electoral roll or were a spouse, partner, or friend nominated by case participants. Data analyses were conducted from October 2017 to February 2018. EXPOSURES: Self- and parent-reported sunscreen use, sun exposure, and other candidate risk factors during childhood and adulthood. MAIN OUTCOMES AND MEASURES: Logistic regression analyses adjusted for potential confounders were used to estimate odds ratios (ORs) for melanoma and for correlates of sunscreen use. RESULTS: Participation was 629 of 830 contactable cases (76%) (629 of 1197 overall [53%]), 240 of 570 contactable controls (42%) from the electoral roll (240 of 1068 overall [23%]), and 295 of 371 nominated spouse or friend controls (80%); analysis incuded 603 cases and 1088 controls. The median (interquartile range) age was 32 (28-36) years for 603 cases, 35 (30-38) years for 478 unrelated controls, and 34 (29-38) years for 610 sibling controls. There were more women than men (range, 57%-62%) in all groups, approximately 40% (range, 39%-43%) of participants had a university education, and most participants (range, 58%-73%) had British/northern European ethnicity. Risk of melanoma was less with higher use of sunscreen in childhood (OR for highest vs lowest tertiles, 0.60; 95% CI, 0.42-0.87; P = .02 for trend) and across the lifetime (OR, 0.65; 95% CI, 0.45-0.93; P = .07 for trend). Subgroup analyses suggested that the protective association of sunscreen with melanoma was stronger for people reporting blistering sunburn, receiving a diagnosis of melanoma at a younger age, or having some or many nevi. Total lifetime sun exposure was unrelated to melanoma risk (OR for highest vs lowest tertile, 0.97; 95% CI, 0.66-1.43; P = .94 for trend). By contrast, total sun exposure inversely weighted by sunscreen use (as a measure of sun exposure unprotected by sunscreen) was significantly associated with melanoma risk (OR, 1.80; 95% CI, 1.22-2.65; P = .007 for trend) and appeared stronger for people having lighter pigmentation or some or many nevi or using sunscreen to stay longer in the sun. Regular users of sunscreen were more likely to be female, younger, and of British or northern European ancestry and to have higher educational levels, lighter skin pigmentation, and a stronger history of blistering sunburn. CONCLUSIONS AND RELEVANCE: Our findings provided evidence that regular sunscreen use is significantly associated with reduced risk of cutaneous melanoma among young adults and identified several characteristics associated with less sunscreen use.
- Published
- 2018
- Full Text
- View/download PDF
23. An assigned responsibility system for robotic teleoperation control
- Author
-
Small, Nicolas, Lee, Kevin, and Mann, Graham
- Abstract
This paper proposes an architecture that explores a gap in the spectrum of existing strategies for robot control mode switching in adjustable autonomy. In situations where the environment is reasonably known and/or predictable, pre-planning these control changes could relieve robot operators of the additional task of deciding when and how to switch. Such a strategy provides a clear division of labour between the automation and the human operator(s) before the job even begins, allowing for individual responsibilities to be known ahead of time, limiting confusion and allowing rest breaks to be planned. Assigned Responsibility is a new form of adjustable autonomy-based teleoperation that allows the selective inclusion of automated control elements at key stages of a robot operation plan’s execution. Progression through these stages is controlled by automatic goal accomplishment tracking. An implementation is evaluated through engineering tests and a usability study, demonstrating the viability of this approach and offering insight into its potential applications.
- Published
- 2018
- Full Text
- View/download PDF
24. Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage Melanoma
- Author
-
Dieng, Mbathio, Kasparian, Nadine A., Cust, Anne E., Costa, Daniel S. J., Tran, Anh, Butow, Phyllis N., Menzies, Scott W., Mann, Graham J., and Morton, Rachael L.
- Abstract
IMPORTANCE: The diagnosis of a life-threatening disease like melanoma can affect all aspects of a person’s life, including health-related quality of life (HRQOL) and psychological aspects of melanoma such as fear of cancer recurrence (FCR). Economic evaluations of psychological interventions require preference-based (utility) instruments that are sensitive to changes in well-being and HRQOL; however, very few studies have evaluated the sensitivity of these instruments when used for people with melanoma. OBJECTIVE: To compare utility scores from the multiple-attribute instrument Assessment of Quality of Life—8-Dimension Scale (AQoL-8D) with the mapped utility scores of the Functional Assessment of Cancer Therapy–Melanoma (FACT-M) and to investigate the sensitivity of both instruments in identifying the influence of FCR on HRQOL. DESIGN, SETTING, AND PARTICIPANTS: This assessment of data from a randomized clinical trial of a psychoeducational intervention to reduce FCR, conducted at 3 high-risk melanoma clinics in Australia, evaluated 164 patients with early-stage melanoma and a high risk of developing a second primary melanoma. MAIN OUTCOMES AND MEASURES: The FACT-M and AQoL-8D were used to assess HRQOL and FCR among the study participants. Concurrent validity was assessed by comparing the total and subdomain scores of the 2 instruments, and the strength of associations was assessed using Pearson correlation coefficient. Convergent validity was assessed by comparing participants’ HRQOL, demographic, and clinical characteristics using the χ2 test and F statistic. Both the FACT-M and AQoL-8D utilities were regressed on FCR Inventory (FCRI) severity scores to estimate the effect of elevated FCR on HRQOL. RESULTS: A total of 164 participants completed the baseline questionnaires, but only 163 met all inclusion criteria and underwent the full analysis: 72 were women; 91 were men; and mean (SD) age was 58.2 (12.1) years. Both the AQoL-8D and FACT-M instruments showed good concurrent validity and could differentiate between relevant subgroups including level of FCRI severity. The AQoL-8D and FACT-M utilities were strongly correlated (r2 = 0.57). Respondents had a mean (SD) AQoL-8D utility of 0.77 (0.2), and a mean (SD) FACT-M utility score of 0.76 (0.07). High levels of FCRI severity were associated with a decrease in utility of 0.12 (95% CI, −0.19 to −0.05) as measured by AQoL-8D, and a decrease of 0.03 (95% CI, −0.05 to −0.01) as measured by the FACT-M. CONCLUSIONS AND RELEVANCE: For economic evaluations of psychological interventions in melanoma, the AQoL-8D and FACT-M are valid measures of utility; however, the AQoL-8D demonstrates greater sensitivity to FCRI severity. Our results suggest a significant association between FCR and HRQOL.
- Published
- 2018
- Full Text
- View/download PDF
25. Germline Variation at CDKN2Aand Associations with Nevus Phenotypes among Members of Melanoma Families
- Author
-
Taylor, Nicholas J., Mitra, Nandita, Goldstein, Alisa M., Tucker, Margaret A., Avril, Marie-Françoise, Azizi, Esther, Bergman, Wilma, Bishop, D. Timothy, Bressac-de Paillerets, Brigitte, Bruno, William, Calista, Donato, Cannon-Albright, Lisa A., Cuellar, Francisco, Cust, Anne E., Demenais, Florence, Elder, David E., Gerdes, Anne-Marie, Ghiorzo, Paola, Grazziotin, Thais C., Hansson, Johan, Harland, Mark, Hayward, Nicholas K., Hocevar, Marko, Höiom, Veronica, Ingvar, Christian, Landi, Maria Teresa, Landman, Gilles, Larre-Borges, Alejandra, Leachman, Sancy A., Mann, Graham J., Nagore, Eduardo, Olsson, Håkan, Palmer, Jane M., Perić, Barbara, Pjanova, Dace, Pritchard, Antonia, Puig, Susana, van der Stoep, Nienke, Wadt, Karin A.W., Whitaker, Linda, Yang, Xiaohong R., Newton Bishop, Julia A., Gruis, Nelleke A., and Kanetsky, Peter A.
- Abstract
Germline mutations in CDKN2Aare frequently identified among melanoma kindreds and are associated with increased atypical nevus counts. However, a clear relationship between pathogenic CDKN2Amutation carriage and other nevus phenotypes including counts of common acquired nevi has not yet been established. Using data from GenoMEL, we investigated the relationships between CDKN2Amutation carriage and 2-mm, 5-mm, and atypical nevus counts among blood-related members of melanoma families. Compared with individuals without a pathogenic mutation, those who carried one had an overall higher prevalence of atypical (odds ratio = 1.64; 95% confidence interval = 1.18–2.28) nevi but not 2-mm nevi (odds ratio = 1.06; 95% confidence interval = 0.92–1.21) or 5-mm nevi (odds ratio = 1.26; 95% confidence interval = 0.94–1.70). Stratification by case status showed more pronounced positive associations among non-case family members, who were nearly three times (odds ratio = 2.91; 95% confidence interval = 1.75–4.82) as likely to exhibit nevus counts at or above the median in all three nevus categories simultaneously when harboring a pathogenic mutation (vs. not harboring one). Our results support the hypothesis that unidentified nevogenic genes are co-inherited with CDKN2Aand may influence carcinogenesis.
- Published
- 2017
- Full Text
- View/download PDF
26. Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center
- Author
-
Varey, Alexander H R, Goumas, Chris, Hong, Angela M, Mann, Graham J, Fogarty, Gerald B, Stretch, Jonathan R, Saw, Robyn P M, Spillane, Andrew J, Shannon, Kerwin F, Lee, Kenneth J, Quinn, Michael J, Thompson, John F, and Scolyer, Richard A
- Abstract
Neurotropic cutaneous melanoma is a rare melanoma subtype that invades nerves and is often associated with desmoplastic melanoma. Limited data suggest that it has a greater propensity to recur locally, but it is unknown whether its behavior differs from that of other melanoma subtypes, including desmoplastic melanoma. We investigated clinicopathological predictors of outcome in a cohort of 671 patients with neurotropic melanoma to develop evidence-based management recommendations. Patients with primary neurotropic melanoma diagnosed from 1985 to 2013 were identified from the Melanoma Institute Australia database, along with a control cohort of 718 non-neurotropic melanoma patients. Features predictive of sentinel lymph node status, recurrence, melanoma-specific survival and response to adjuvant radiotherapy were sought. Neither local recurrence (hazard ratio: 1.28 (0.73–2.25) P=0.39) nor melanoma-specific survival (hazard ratio: 0.79 (0.55–1.15) P=0.22) were significantly affected by the presence of neurotropism on multivariate analysis. However, there was a markedly reduced likelihood of sentinel node positivity (hazard ratio: 0.61 (0.41–0.89) P=0.01) in neurotropic melanoma patients. Surgical margins ≥8mm halved the recurrence risk compared with <2 mm margins (hazard ratio: 0.46 (0.31–0.68) P<0.001). Additionally, in neurotropic melanoma patients with <8 mm margins, adjuvant radiotherapy halved the recurrence risk (hazard ratio: 0.48 (0.27–0.87) P=0.02). This, the largest study of neurotropic melanoma reported to date, has demonstrated that the presence of neurotropism does not alter the risk of melanoma recurrence or survival but does reduce the likelihood of sentinel node positivity. For successful treatment of neurotropic melanoma, adequate excision margins are of paramount importance. However, when adequate margins cannot be achieved, adjuvant radiotherapy reduces the risk of recurrence.
- Published
- 2017
- Full Text
- View/download PDF
27. Strong constraints on aerosol–cloud interactions from volcanic eruptions
- Author
-
Malavelle, Florent F., Haywood, Jim M., Jones, Andy, Gettelman, Andrew, Clarisse, Lieven, Bauduin, Sophie, Allan, Richard P., Karset, Inger Helene H., Kristjánsson, Jón Egill, Oreopoulos, Lazaros, Cho, Nayeong, Lee, Dongmin, Bellouin, Nicolas, Boucher, Olivier, Grosvenor, Daniel P., Carslaw, Ken S., Dhomse, Sandip, Mann, Graham W., Schmidt, Anja, Coe, Hugh, Hartley, Margaret E., Dalvi, Mohit, Hill, Adrian A., Johnson, Ben T., Johnson, Colin E., Knight, Jeff R., O’Connor, Fiona M., Partridge, Daniel G., Stier, Philip, Myhre, Gunnar, Platnick, Steven, Stephens, Graeme L., Takahashi, Hanii, and Thordarson, Thorvaldur
- Abstract
Aerosols have a potentially large effect on climate, particularly through their interactions with clouds, but the magnitude of this effect is highly uncertain. Large volcanic eruptions produce sulfur dioxide, which in turn produces aerosols; these eruptions thus represent a natural experiment through which to quantify aerosol–cloud interactions. Here we show that the massive 2014–2015 fissure eruption in Holuhraun, Iceland, reduced the size of liquid cloud droplets—consistent with expectations—but had no discernible effect on other cloud properties. The reduction in droplet size led to cloud brightening and global-mean radiative forcing of around −0.2 watts per square metre for September to October 2014. Changes in cloud amount or cloud liquid water path, however, were undetectable, indicating that these indirect effects, and cloud systems in general, are well buffered against aerosol changes. This result will reduce uncertainties in future climate projections, because we are now able to reject results from climate models with an excessive liquid-water-path response.
- Published
- 2017
- Full Text
- View/download PDF
28. Whole-genome landscapes of major melanoma subtypes
- Author
-
Hayward, Nicholas K., Wilmott, James S., Waddell, Nicola, Johansson, Peter A., Field, Matthew A., Nones, Katia, Patch, Ann-Marie, Kakavand, Hojabr, Alexandrov, Ludmil B., Burke, Hazel, Jakrot, Valerie, Kazakoff, Stephen, Holmes, Oliver, Leonard, Conrad, Sabarinathan, Radhakrishnan, Mularoni, Loris, Wood, Scott, Xu, Qinying, Waddell, Nick, Tembe, Varsha, Pupo, Gulietta M., De Paoli-Iseppi, Ricardo, Vilain, Ricardo E., Shang, Ping, Lau, Loretta M. S., Dagg, Rebecca A., Schramm, Sarah-Jane, Pritchard, Antonia, Dutton-Regester, Ken, Newell, Felicity, Fitzgerald, Anna, Shang, Catherine A., Grimmond, Sean M., Pickett, Hilda A., Yang, Jean Y., Stretch, Jonathan R., Behren, Andreas, Kefford, Richard F., Hersey, Peter, Long, Georgina V., Cebon, Jonathan, Shackleton, Mark, Spillane, Andrew J., Saw, Robyn P. M., López-Bigas, Núria, Pearson, John V., Thompson, John F., Scolyer, Richard A., and Mann, Graham J.
- Abstract
Melanoma of the skin is a common cancer only in Europeans, whereas it arises in internal body surfaces (mucosal sites) and on the hands and feet (acral sites) in people throughout the world. Here we report analysis of whole-genome sequences from cutaneous, acral and mucosal subtypes of melanoma. The heavily mutated landscape of coding and non-coding mutations in cutaneous melanoma resolved novel signatures of mutagenesis attributable to ultraviolet radiation. However, acral and mucosal melanomas were dominated by structural changes and mutation signatures of unknown aetiology, not previously identified in melanoma. The number of genes affected by recurrent mutations disrupting non-coding sequences was similar to that affected by recurrent mutations to coding sequences. Significantly mutated genes included BRAF, CDKN2A, NRAS and TP53 in cutaneous melanoma, BRAF, NRAS and NF1 in acral melanoma and SF3B1 in mucosal melanoma. Mutations affecting the TERT promoter were the most frequent of all; however, neither they nor ATRX mutations, which correlate with alternative telomere lengthening, were associated with greater telomere length. Most melanomas had potentially actionable mutations, most in components of the mitogen-activated protein kinase and phosphoinositol kinase pathways. The whole-genome mutation landscape of melanoma reveals diverse carcinogenic processes across its subtypes, some unrelated to sun exposure, and extends potential involvement of the non-coding genome in its pathogenesis.
- Published
- 2017
- Full Text
- View/download PDF
29. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas
- Author
-
Rawson, Robert V, Johansson, Peter A, Hayward, Nicholas K, Waddell, Nicola, Patch, Ann-Marie, Lo, Serigne, Pearson, John V, Thompson, John F, Mann, Graham J, Scolyer, Richard A, and Wilmott, James S
- Abstract
Ultraviolet radiation (UVR) mutagenesis causes nearly all cutaneous melanomas, however, since UVR signatures are largely absent in acral melanoma, as well as melanoma in sun-protected sites, the cause of these melanomas is unknown. Whole-genome sequencing data generated as part of the Australian Melanoma Genome Project was supplemented with a detailed histopathological assessment with the melanomas then classified as UVR or non-UVR related, based on their mutation signatures. The clinicopathological characteristics of melanomas with mutation signatures for their subtype were compared. Three (of 35=8.6%) acral melanomas, all clinically and pathologically verified as arising from acral or subungual locations, had predominant UVR mutation burden, whereas four (of 140=2.9%) cutaneous melanomas showed predominant non-UVR mutations. Among the acral melanomas, the few that were UVR dominant occurred in younger patients, had a higher mutation load and a proportion of mutation burden due to UVR, which was similar to that in melanomas from intermittently UVR-exposed skin. Acral melanomas with a UVR signature occurred most frequently in subungual sites and included tumors harboring BRAF or NF1 mutations. Cutaneous melanomas dominated by non-UVR signatures had lower mutation burdens counts and their primary tumors were thicker and had more mitoses than in other cutaneous melanomas. No histopathological features predicted UVR dominance in acral melanomas or non-UVR dominance in cutaneous melanomas. Our finding of acral/subungual melanomas with predominant UVR mutagenesis suggests that the nail plate and acral skin do not provide complete protection from UVR. Our data also confirm that cutaneous melanomas not caused by UVR are infrequent. Identifying where mutation burden is discordant with primary tumor anatomical site is likely to be clinically significant when determining treatment options for metastatic acral and cutaneous melanoma patients.
- Published
- 2017
- Full Text
- View/download PDF
30. Germline CDKN2A/P16INK4A mutations contribute to genetic determinism of sarcoma
- Author
-
Jouenne, Fanélie, Chauvot de Beauchene, Isaure, Bollaert, Emeline, Avril, Marie-Francoise, Caron, Olivier, Ingster, Olivier, Lecesne, Axel, Benusiglio, Patrick, Terrier, Philippe, Caumette, Vincent, Pissaloux, Daniel, de la Fouchardiéère, Arnaud, Cabaret, Odile, N’Diaye, Birama, Velghe, Améèélie, Bougeard, Gaelle, Mann, Graham J, Koscielny, Serge, Barrett, Jennifer H, Harland, Mark, Newton-Bishop, Julia, Gruis, Nelleke, Van Doorn, Remco, Gauthier-Villars, Marion, Pierron, Gaelle, Stoppa-Lyonnet, Dominique, Coupier, Isabelle, Guimbaud, Rosine, Delnatte, Capucine, Scoazec, Jean-Yves, Eggermont, Alexander M, Feunteun, Jean, Tchertanov, Luba, Demoulin, Jean-Baptiste, Frebourg, Thierry, and Bressac-de Paillerets, Brigitte
- Abstract
BackgroundSarcomas are rare mesenchymal malignancies whose pathogenesis is poorly understood; both environmental and genetic risk factors could contribute to their aetiology.Methods and resultsWe performed whole-exome sequencing (WES) in a familial aggregation of three individuals affected with soft-tissue sarcoma (STS) without TP53 mutation (Li-Fraumeni-like, LFL) and found a shared pathogenic mutation in CDKN2Atumour suppressor gene. We searched for individuals with sarcoma among 474 melanoma-prone families with a CDKN2A-/+ genotype and for CDKN2Amutations in 190 TP53-negative LFL families where the index case was a sarcoma. Including the initial family, eight independent sarcoma cases carried a germline mutation in the CDKN2A/p16INK4Agene. In five out of seven formalin-fixed paraffin-embedded sarcomas, heterozygosity was lost at germline CDKN2Amutations sites demonstrating complete loss of function. As sarcomas are rare in CDKN2A/p16INK4Acarriers, we searched in constitutional WES of nine carriers for potential modifying rare variants and identified three in platelet-derived growth factor receptor (PDGFRA) gene. Molecular modelling showed that two never-described variants could impact the PDGFRA extracellular domain structure.ConclusionGermline mutations in CDKN2A/P16INK4A, a gene known to predispose to hereditary melanoma, pancreatic cancer and tobacco-related cancers, account also for a subset of hereditary sarcoma. In addition, we identified PDGFRAas a candidate modifier gene.
- Published
- 2017
- Full Text
- View/download PDF
31. Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study
- Author
-
Watts, Caroline G., Madronio, Christine, Morton, Rachael L., Goumas, Chris, Armstrong, Bruce K., Curtin, Austin, Menzies, Scott W., Mann, Graham J., Thompson, John F., and Cust, Anne E.
- Abstract
IMPORTANCE: The identification of a subgroup at higher risk of melanoma may assist in early diagnosis. OBJECTIVE: To characterize melanoma patients and the clinical features associated with their melanomas according to patient risk factors: many nevi, history of previous melanoma, and family history of melanoma, to assist with improving the identification and treatment of a higher-risk subgroup. DESIGN, SETTING, AND PARTICIPANTS: The Melanoma Patterns of Care study was a population-based observational study of physicians’ reported treatment of 2727 patients diagnosed with an in situ or invasive primary melanoma over a 12-month period from October 2006 to 2007 conducted in New South Wales. Our analysis of these data took place from 2015 to 2016. MAIN OUTCOMES AND MEASURES: Age at diagnosis and body site of melanoma. RESULTS: Of the 2727 patients with melanoma included, 1052 (39%) were defined as higher risk owing to a family history of melanoma, multiple primary melanomas, or many nevi. Compared with patients with melanoma who were at lower risk (ie, without any of these risk factors), the higher-risk group had a younger mean age at diagnosis (62 vs 65 years, P < .001), but this differed by risk factor (56 years for patients with a family history, 59 years for those with many nevi, and 69 years for those with a previous melanoma). These age differences were consistent across all body sites. Among higher-risk patients, those with many nevi were more likely to have melanoma on the trunk (41% vs 29%, P < .001), those with a family history of melanoma were more likely to have melanomas on the limbs (57% vs 42%, P < .001), and those with a personal history were more likely to have melanoma on the head and neck (21% vs 15%, P = .003). CONCLUSIONS AND RELEVANCE: These findings suggest that a person’s risk factor status could be used to tailor surveillance programs and education about skin self-examination.
- Published
- 2017
- Full Text
- View/download PDF
32. Melanoma Explorer: a web application to allow easy reanalysis of publicly available and clinically annotated melanoma omics data sets
- Author
-
Strbenac, Dario, Wang, Kevin, Wang, Xinyue, Dong, Jiamin, Mann, Graham J., Mueller, Samuel, and Yang, Jean Y.H.
- Abstract
Supplemental Digital Content is available in the text.Validating newly discovered biomarkers in large, publicly available data sets is often difficult and requires specialized computer programming skills. Melanoma Explorer is a web application that enables easy interrogation of melanoma omics data sets that are freely available in online data repositories with a point-and-click interface. Two use cases are demonstrated. First, the relationship of lysozyme mRNA expression is shown to be prognostic in two independent gene expression microarray data sets. Second, a figure from a journal article showing the relationship of tumour thickness and miR-382 abundance is reproduced. Melanoma Explorer is demonstrated to be a useful tool for reproducing results of published studies and providing additional evidence for biomarkers in independent data sets.
- Published
- 2019
- Full Text
- View/download PDF
33. Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors
- Author
-
Vuong, Kylie, Armstrong, Bruce K., Weiderpass, Elisabete, Lund, Eiliv, Adami, Hans-Olov, Veierod, Marit B., Barrett, Jennifer H., Davies, John R., Bishop, D. Timothy, Whiteman, David C., Olsen, Catherine M., Hopper, John L., Mann, Graham J., Cust, Anne E., and McGeechan, Kevin
- Abstract
IMPORTANCE: Identifying individuals at high risk of melanoma can optimize primary and secondary prevention strategies. OBJECTIVE: To develop and externally validate a risk prediction model for incident first-primary cutaneous melanoma using self-assessed risk factors. DESIGN, SETTING, AND PARTICIPANTS: We used unconditional logistic regression to develop a multivariable risk prediction model. Relative risk estimates from the model were combined with Australian melanoma incidence and competing mortality rates to obtain absolute risk estimates. A risk prediction model was developed using the Australian Melanoma Family Study (629 cases and 535 controls) and externally validated using 4 independent population-based studies: the Western Australia Melanoma Study (511 case-control pairs), Leeds Melanoma Case-Control Study (960 cases and 513 controls), Epigene-QSkin Study (44 544, of which 766 with melanoma), and Swedish Women’s Lifestyle and Health Cohort Study (49 259 women, of which 273 had melanoma). MAIN OUTCOMES AND MEASURES: We validated model performance internally and externally by assessing discrimination using the area under the receiver operating curve (AUC). Additionally, using the Swedish Women’s Lifestyle and Health Cohort Study, we assessed model calibration and clinical usefulness. RESULTS: The risk prediction model included hair color, nevus density, first-degree family history of melanoma, previous nonmelanoma skin cancer, and lifetime sunbed use. On internal validation, the AUC was 0.70 (95% CI, 0.67-0.73). On external validation, the AUC was 0.66 (95% CI, 0.63-0.69) in the Western Australia Melanoma Study, 0.67 (95% CI, 0.65-0.70) in the Leeds Melanoma Case-Control Study, 0.64 (95% CI, 0.62-0.66) in the Epigene-QSkin Study, and 0.63 (95% CI, 0.60-0.67) in the Swedish Women’s Lifestyle and Health Cohort Study. Model calibration showed close agreement between predicted and observed numbers of incident melanomas across all deciles of predicted risk. In the external validation setting, there was higher net benefit when using the risk prediction model to classify individuals as high risk compared with classifying all individuals as high risk. CONCLUSIONS AND RELEVANCE: The melanoma risk prediction model performs well and may be useful in prevention interventions reliant on a risk assessment using self-assessed risk factors.
- Published
- 2016
- Full Text
- View/download PDF
34. Phenotypic and Histopathological Tumor Characteristics According to CDKN2AMutation Status among Affected Members of Melanoma Families
- Author
-
Taylor, Nicholas J., Handorf, Elizabeth A., Mitra, Nandita, Avril, Marie-Françoise, Azizi, Esther, Bergman, Wilma, Bianchi-Scarrà, Giovanna, Bishop, D. Timothy, Bressac-de Paillerets, Brigitte, Calista, Donato, Cannon-Albright, Lisa A., Cuellar, Francisco, Cust, Anne E., Demenais, Florence, Elder, David E., Friedman, Eitan, Gerdes, Anne-Marie, Ghiorzo, Paola, Goldstein, Alisa M., Grazziotin, Thais C., Hansson, Johan, Hayward, Nicholas K., Hocevar, Marko, Höiom, Veronica, Holland, Elizabeth A., Ingvar, Christian, Landi, Maria Teresa, Landman, Gilles, Larre-Borges, Alejandra, Leachman, Sancy A., Mann, Graham J., Nagore, Eduardo, Olsson, Håkan, Palmer, Jane, Perić, Barbara, Pjanova, Dace, Puig, Susana, Schmid, Helen, van der Stoep, Nienke, Tucker, Margaret A., Wadt, Karin A.W., Whitaker, Linda, Yang, Xiaohong R., Newton Bishop, Julia A., Gruis, Nelleke A., and Kanetsky, Peter A.
- Published
- 2016
- Full Text
- View/download PDF
35. Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making
- Author
-
De Paoli-Iseppi, Ricardo, Johansson, Peter A., Menzies, Alexander M., Dias, Kerith-Rae, Pupo, Gulietta M., Kakavand, Hojabr, Wilmott, James S., Mann, Graham J., Hayward, Nicholas K., Dinger, Marcel E., Long, Georgina V., and Scolyer, Richard A.
- Abstract
The identification of recurrent driver mutations by whole-exome sequencing (WES) of fresh-frozen human cancers and the subsequent development of novel targeted therapies have recently transformed the treatment of many cancers including melanoma. In routine clinical practice, fresh-frozen tissue is rarely available and mutation testing usually needs to be carried out on archival formalin fixed, paraffin embedded (FFPE) tissue, from which DNA is typically fragmented, cross-linked and of lower quality.
- Published
- 2016
- Full Text
- View/download PDF
36. The molecular profile of metastatic melanoma in Australia
- Author
-
Lyle, Megan, Haydu, Lauren E., Menzies, Alexander M., Thompson, John F., Saw, Robyn P.M., Spillane, Andrew J., Kefford, Richard F., Mann, Graham J., Cooper, Wendy A., Yu, Bing, Scolyer, Richard A., O'Toole, Sandra A., and Long, Georgina V.
- Abstract
Targeted therapy directed at driver oncogenic mutations offers an effective treatment option for select patients with metastatic melanoma. The aim of this study was to assess the prevalence of clinically significant somatic mutations, specifically BRAF, NRASand KIT, in a large cohort of Australian patients with metastatic melanoma. We performed a cross-sectional cohort study of consecutive patients with American Joint Committee on Cancer (AJCC) stage IIIc unresectable or stage IV melanoma managed at Melanoma Institute Australia, and affiliated sites, that underwent molecular testing between 22 June 2009 and 19 July 2013. Additionally, we examined the change in BRAFtesting methodology and patient population over time, and how this influenced the prevalence of mutations. A total of 767 molecular tests were conducted for 733 patients. BRAFV600 mutation testing was performed for 713 patients (97.2%), with an overall mutation prevalence of 37.7% (269/713); 74.3% (200/269) were the V600E genotype and 22.3% (60/269) V600K. The BRAFmutation prevalence and proportion of BRAFV600E and V600K genotypes varied across the study period, as did testing methodology and the median age of the cohorts. Of 222 patients who underwent NRAStesting, 58 (26.1%) had a mutation identified. The overall prevalence of KITmutations was 3.7% (11/296). In Australia the prevalence of BRAFmutations is lower than initially reported, although this remains the most common mutation identified in metastatic melanoma and an important therapeutic target. NRASmutations are more prevalent than initially described; however, other mutations reported in melanoma, including KIT, are rare in an unselected population of patients.
- Published
- 2016
- Full Text
- View/download PDF
37. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma
- Author
-
Jayawardana, Kaushala, Schramm, Sarah-Jane, Tembe, Varsha, Mueller, Samuel, Thompson, John F., Scolyer, Richard A., Mann, Graham J., and Yang, Jean
- Abstract
In metastatic melanoma, it is vital to identify and validate biomarkers of prognosis. Previous studies have systematically evaluated protein biomarkers or mRNA-based expression signatures. No such analyses have been applied to microRNA (miRNA)-based prognostic signatures. As a first step, we identified two prognostic miRNA signatures from publicly available data sets (Gene Expression Omnibus/The Cancer Genome Atlas) of global miRNA expression profiling information. A 12-miRNA signature predicted longer survival after surgery for resection of American Joint Committee on Cancer stage III disease (>4 years, no sign of relapse) and outperformed American Joint Committee on Cancer standard-of-care prognostic markers in leave-one-out cross-validation analysis (error rates 34% and 38%, respectively). A similar 15-miRNA biomarker derived from The Cancer Genome Atlas miRNA-seq data performed slightly worse (39%) than these current biomarkers. Both signatures were then assessed for replication in two independent data sets and subjected to systematic cross-validation together with the three other miRNA-based prognostic signatures proposed in the literature to date. Five miRNAs (miR-142-5p, miR-150-5p, miR-342-3p, miR-155-5p, and miR-146b-5p) were reproducibly associated with patient outcome and have the greatest potential for application in the clinic. Our extensive validation approach highlighted among multiple independent cohorts the translational potential and limitations of miRNA signatures, and pointed to future directions in the analysis of this emerging class of markers.
- Published
- 2016
- Full Text
- View/download PDF
38. Selective environmental stress from sulphur emitted by continental flood basalt eruptions
- Author
-
Schmidt, Anja, Skeffington, Richard A., Thordarson, Thorvaldur, Self, Stephen, Forster, Piers M., Rap, Alexandru, Ridgwell, Andy, Fowler, David, Wilson, Marjorie, Mann, Graham W., Wignall, Paul B., and Carslaw, Kenneth S.
- Abstract
Several biotic crises during the past 300 million years have been linked to episodes of continental flood basalt volcanism, and in particular to the release of massive quantities of magmatic sulphur gas species. Flood basalt provinces were typically formed by numerous individual eruptions, each lasting years to decades. However, the environmental impact of these eruptions may have been limited by the occurrence of quiescent periods that lasted hundreds to thousands of years. Here we use a global aerosol model to quantify the sulphur-induced environmental effects of individual, decade-long flood basalt eruptions representative of the Columbia River Basalt Group, 16.5–14.5 million years ago, and the Deccan Traps, 65 million years ago. For a decade-long eruption of Deccan scale, we calculate a decadal-mean reduction in global surface temperature of 4.5 K, which would recover within 50 years after an eruption ceased unless climate feedbacks were very different in deep-time climates. Acid mists and fogs could have caused immediate damage to vegetation in some regions, but acid-sensitive land and marine ecosystems were well-buffered against volcanic sulphur deposition effects even during century-long eruptions. We conclude that magmatic sulphur from flood basalt eruptions would have caused a biotic crisis only if eruption frequencies and lava discharge rates had been high and sustained for several centuries at a time.
- Published
- 2016
- Full Text
- View/download PDF
39. Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes
- Author
-
Wilmott, James S., Field, Matthew A., Johansson, Peter A., Kakavand, Hojabr, Shang, Ping, De Paoli-Iseppi, Ricardo, Vilain, Ricardo E., Pupo, Gulietta M., Tembe, Varsha, Jakrot, Valerie, Shang, Catherine A., Cebon, Jonathan, Shackleton, Mark, Fitzgerald, Anna, Thompson, John F., Hayward, Nicholas K., Mann, Graham J., and Scolyer, Richard A.
- Abstract
Whole genome sequencing (WGS) of cancer patients’ tumours offers the most comprehensive method of identifying both novel and known clinically-actionable genomic targets. However, the practicalities of performing WGS on clinical samples are poorly defined. This study was designed to test sample preparation, sequencing specifications and bioinformatic algorithms for their effect on accuracy and cost-efficiency in a large WGS analysis of human melanoma samples. WGS was performed on melanoma cell lines (n=15) and melanoma fresh frozen tumours (n=222). The appropriate level of coverage and the optimal mutation detection algorithm for the project pipeline were determined. An incremental increase in sequencing coverage from 36X to 132X in melanoma tissue samples and 30X to 103X for cell lines only resulted in a small increase (1–2%) in the number of mutations detected, and the quality scores of the additional mutations indicated a low probability that the mutations were real. The results suggest that 60X coverage for melanoma tissue and 40X for melanoma cell lines empower the detection of 98–99% of informative single nucleotide variants (SNVs), a sensitivity level at which clinical decision making or landscape research projects can be carried out with a high degree of confidence in the results. Likewise the bioinformatic mutation analysis methodology strongly influenced the number and quality of SNVs detected. Detecting mutations in the blood genomes separate to the tumour genomes generated 41% more SNVs than if the blood and melanoma tissue genomes were analysed simultaneously. Therefore, simultaneous analysis should be employed on matched melanoma tissue and blood genomes to reduce errors in mutation detection. This study provided valuable insights into the accuracy of SNV with WGS at various coverage levels in human clinical cancer specimens. Additionally, we investigated the accuracy of the publicly available mutation detection algorithms to detect cancer specific SNVs which will aid researchers and clinicians in study design and implementation of WGS for the identification of somatic mutations in other cancers.
- Published
- 2015
- Full Text
- View/download PDF
40. Specialized Surveillance for Individuals at High Risk for Melanoma: A Cost Analysis of a High-Risk Clinic
- Author
-
Watts, Caroline G., Cust, Anne E., Menzies, Scott W., Coates, Elliot, Mann, Graham J., and Morton, Rachael L.
- Abstract
IMPORTANCE: Regular surveillance of individuals at high risk for cutaneous melanoma improves early detection and reduces unnecessary excisions; however, a cost analysis of this specialized service has not been undertaken. OBJECTIVE: To determine the mean cost per patient of surveillance in a high-risk clinic from the health service and societal perspectives. DESIGN, SETTING, AND PARTICIPANTS: We used a bottom-up microcosting method to measure resource use in a consecutive sample of 102 patients treated in a high-risk hospital-based clinic in Australia during a 12-month period. EXPOSURE: Surveillance and treatment of melanoma. MAIN OUTCOMES AND MEASURES: All surveillance and treatment procedures were identified through direct observation, review of medical records, and interviews with staff and were valued using scheduled fees from the Australian government. Societal costs included transportation and loss of productivity. RESULTS: The mean number of clinic visits per year was 2.7 (95% CI, 2.5-2.8) for surveillance and 3.8 (95% CI, 3.4-4.1) for patients requiring surgical excisions. The mean annual cost per patient to the health system was A $882 (95% CI, A $783-$982) (US $599 [95% CI, US $532-$665]); the cost discounted across 20 years was A $11 546 (95% CI, A $10 263-$12 829) (US $7839 [95% CI, US $6969-$8710]). The mean annual societal cost per patient (excluding health system costs) was A $972 (95% CI, A $899-$1045) (US $660 [95% CI, US $611-$710]); the cost discounted across 20 years was A $12 721 (95% CI, A $12 554-$14 463) (US $8637 [95% CI, US $8523-$9820]). Diagnosis of melanoma or nonmelanoma skin cancer and frequent excisions for benign lesions in a relatively small number of patients was responsible for positively skewed health system costs. CONCLUSIONS AND RELEVANCE: Microcosting techniques provide an accurate cost estimate for the provision of a specialized service. The high societal cost reflects the time that patients are willing to invest to attend the high-risk clinic. This alternative model of care for a high-risk population has relevance for decision making about health policy.
- Published
- 2015
- Full Text
- View/download PDF
41. Advantages of Whole-Genome Sequencing for Identification of Tumor Etiology and Clinically Actionable Genomic Aberrations: Lessons from the Australian Melanoma Genome Project
- Author
-
Wilmott, James S, Hayward, Nicholas K, Mann, Graham J, and Scolyer, Richard A
- Published
- 2017
- Full Text
- View/download PDF
42. Detection of Primary Melanoma in Individuals at Extreme High Risk: A Prospective 5-Year Follow-up Study
- Author
-
Moloney, Fergal J., Guitera, Pascale, Coates, Elliot, Haass, Nikolas K., Ho, Kenneth, Khoury, Ritta, O'Connell, Rachel L., Raudonikis, Leo, Schmid, Helen, Mann, Graham J., and Menzies, Scott W.
- Abstract
IMPORTANCE: The clinical phenotype and certain predisposing genetic mutations that confer increased melanoma risk are established; however, no consensus exists regarding optimal screening for such individuals. Early identification remains the most important intervention in reducing melanoma mortality. OBJECTIVE: To evaluate the impact of full-body examinations every 6 months supported by dermoscopy and total-body photography (TBP) on all patients and sequential digital dermoscopy imaging (SDDI), when indicated, on detecting primary melanoma in an extreme-risk population. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational study from February 2006 to February 2011, with patients recruited from Sydney Melanoma Diagnostic Centre and Melanoma Institute Australia who had a history of invasive melanoma and dysplastic nevus syndrome, history of invasive melanoma and at least 3 first-degree or second-degree relatives with prior melanoma, history of at least 2 primary invasive melanomas, or a CDKN2A or CDK4 gene mutation. EXPOSURES: Six-month full-body examination compared with TBP. For equivocal lesions, SDDI short term (approximately 3 months) or long term (≥6 months), following established criteria, was performed. Atypical lesions were excised. MAIN OUTCOMES AND MEASURES: New primary melanoma numbers, characteristics, and cumulative incidence in each patient subgroup; effect of diagnostic aids on new melanoma identification. RESULTS: In 311 patients with a median (interquartile range [IQR]) follow-up of 3.5 (2.4-4.2) years, 75 primary melanomas were detected, 14 at baseline visit. Median (IQR) Breslow thickness of postbaseline incident melanomas was in situ (in situ to 0.60 mm). Thirty-eight percent were detected using TBP and 39% with SDDI. Five melanomas were greater than 1 mm Breslow thickness, 3 of which were histologically desmoplastic; the other 2 had nodular components. The benign to malignant excision ratio was 1.6:1 for all lesions excised and 4.4:1 for melanocytic lesions. Cumulative risk of developing a novel primary melanoma was 12.7% by year 2, with new primary melanoma incidence during the final 3 years of follow-up half of that observed during the first 2 years (incidence density ratio, 0.43 [95% CI, 0.25-0.74]; P = .002). CONCLUSIONS AND RELEVANCE: Monitoring patients at extreme risk with TBP and SDDI assisted with early diagnosis of primary melanoma. Hypervigilance for difficult-to-detect thick melanoma subtypes is crucial.
- Published
- 2014
- Full Text
- View/download PDF
43. Cellular blue naevus involving the urinary bladder
- Author
-
Kim, Jennifer, McCarthy, Stanley W., Thompson, John F., Pupo, Gulietta M., Vonthethoff, Leon, Nash, Peter, Mann, Graham J., and Scolyer, Richard A.
- Published
- 2012
- Full Text
- View/download PDF
44. Functional impairment of p16INK4A due to CDKN2A p.Gly23Asp missense mutation
- Author
-
Scaini, Maria Chiara, Rossi, Elisabetta, de Siqueira Torres, Paula Lobao Antunes, Zullato, Daniela, Callegaro, Monia, Casella, Cinzia, Quaggio, Monica, Agata, Simona, Malacrida, Sandro, Chiarion-Sileni, Vanna, Vecchiato, Antonella, Alaibac, Mauro, Montagna, Marco, Mann, Graham J., Menin, Chiara, and D’Andrea, Emma
- Abstract
The CDKN2A locus encodes for two distinct tumor suppressor proteins, p16INK4A and p14ARF, involved in cell cycle regulation. CDKN2A germline mutations have been associated with familial predisposition to melanoma and other tumor types. Besides bona-fide pathogenic mutations, many sequence variants have been identified, but their effect is not well known. We detected the p.Gly23Asp missense mutation in one of the two tested melanoma patients of a family with three melanoma cases. Even though the mutated amino acid is located in a conserved domain that specifically binds to and blocks the function of CDK4/6, its lack of segregation with disease suggested a series of functional assays to discriminate between a pathogenic variant and a neutral polymorphism. The effect of this mutation has been investigated exploiting four p16INK4A properties: its ability (i) to bind CDK4, (ii) to inhibit pRb phosphorylation, (iii) to evenly localize in the cell, and (iv) to cause cell cycle arrest. The mutant protein properties were evaluated transfecting three different cell lines (U2-OS and NM-39, both p16-null, and SaOS 2, p53 and pRb-null) with plasmids expressing either p16wt, p1623Asp, or the p1632Pro pathogenic variant. We found that p1623Asp was less efficient than p16wt in CDK4 binding, in inhibiting pRb phosphorylation, in inducing G1 cell cycle arrest; moreover, its pattern of distribution throughout the cell was suggestive of protein aggregation, thus assessing a pathogenic role for p1623Asp in familial melanoma.
- Published
- 2009
- Full Text
- View/download PDF
45. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situhybridisation
- Author
-
Morey, Adrienne L., Murali, Rajmohan, McCarthy, Stanley W., Mann, Graham J., and Scolyer, Richard A.
- Abstract
Accurate classification of primary melanocytic tumours as benign or malignant is crucial for prognostic prediction and appropriate patient management. Several chromosomal aberrations have been frequently identified in melanomas, but are absent in melanocytic naevi. We performed four-colour fluorescence in situhybridisation (FISH) analysis of melanocytic tumours to determine the accuracy of the technique in classifying melanocytic tumours as benign or malignant.
- Published
- 2009
- Full Text
- View/download PDF
46. Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families
- Author
-
Kasparian, Nadine A, Meiser, Bettina, Butow, Phyllis N, Simpson, Judy M, and Mann, Graham J
- Abstract
Purpose: The aim of this prospective cohort study was to examine uptake and psychological, behavioral, and cognitive outcomes of genetic testing for melanoma risk among individuals with a known family-specific CDKN2A mutation.Methods: A total of 119 individuals were ascertained via a genetic epidemiological study and completed a series of mailed, self-administered questionnaires at multiple time points, including notification of genetic test availability, and 2 weeks and 12 months after receipt of genetic test results (for “test participants”), or 12 months after notification (for “decliners”).Results: Since January 2005, 21% of participants (n = 25) have undergone genetic testing, with 75% of those who have received results identified as mutation carriers (n = 15). Factors associated with uptake of genetic counseling included perceived susceptibility to melanoma (odds ratio = 3.60, P = 0.0008), and fatalistic beliefs about melanoma (odds ratio = 0.57, P = 0.005). Compared with baseline, carriers reported significantly reduced anxiety scores at 2 weeks, and reduced depression scores at 2 weeks and 12 months, after receipt of genetic test results. Carriers also reported a significantly greater frequency of clinical skin examination at 12-month follow-up compared with decliners (?2= 5.70, P = 0.02). No hypothesis testing was carried out for noncarriers because of their limited number.Conclusion: These data provide preliminary evidence for healthy psychological, behavioral, and cognitive adjustment after participation in genetic testing for melanoma risk.
- Published
- 2009
- Full Text
- View/download PDF
47. Recurrent inactivating RASA2 mutations in melanoma
- Author
-
Arafeh, Rand, Qutob, Nouar, Emmanuel, Rafi, Keren-Paz, Alona, Madore, Jason, Elkahloun, Abdel, Wilmott, James S, Gartner, Jared J, Di Pizio, Antonella, Winograd-Katz, Sabina, Sindiri, Sivasish, Rotkopf, Ron, Dutton-Regester, Ken, Johansson, Peter, Pritchard, Antonia L, Waddell, Nicola, Hill, Victoria K, Lin, Jimmy C, Hevroni, Yael, Rosenberg, Steven A, Khan, Javed, Ben-Dor, Shifra, Niv, Masha Y, Ulitsky, Igor, Mann, Graham J, Scolyer, Richard A, Hayward, Nicholas K, and Samuels, Yardena
- Abstract
Analysis of 501 melanoma exomes identified RASA2, encoding a RasGAP, as a tumor-suppressor gene mutated in 5% of melanomas. Recurrent loss-of-function mutations in RASA2 were found to increase RAS activation, melanoma cell growth and migration. RASA2 expression was lost in ≥30% of human melanomas and was associated with reduced patient survival. These findings identify RASA2 inactivation as a melanoma driver and highlight the importance of RasGAPs in cancer.
- Published
- 2015
- Full Text
- View/download PDF
48. Erratum to: BCoR-L1variation and breast cancer
- Author
-
Lose, Felicity, Arnold, Jeremy, Young, David, Brown, Carolyn, Mann, Graham, Pupo, Gulietta, Khanna, Kum, Chenevix-Trench, Georgia, and Spurdle, Amanda
- Published
- 2008
- Full Text
- View/download PDF
49. Digital television, Personal Video Recorders and Media, Automation, Data and Entertainment convergence in the home
- Author
-
Mann, Graham and Bernsteins, Indulis
- Abstract
Out of the confusion of possible delivery technologies for domestic digital video entertainment, the personal video recorder (PVR) with an electronic program guide (EPG) emerges as a key component. Serving as a content manager for video broadcasts, PVRs can automatically record, sort, schedule, store and integrate video material from different sources in a convenient, easy-to-use and timely fashion. Such devices are gradually being adopted in the homes of the developed world, and are the increasing subject of pioneering commercial enterprise, innovative experimentation and open-source community development. Going one step further, the concept of a 'MADE system' is introduced as a system with converged functionality for media, automation, data and entertainment. This article describes and compares three systems with PVR functionality and evaluates their current and future roles as a component for MADE systems. The drivers for and threats to the convergence of functionality towards a MADE system are also considered.
- Published
- 2008
50. BCoR-L1variation and breast cancer
- Author
-
Lose, Felicity, Arnold, Jeremy, Young, David, Brown, Carolyn, Mann, Graham, Pupo, Gulietta, Khanna, Kum, Chenevix-Trench, Georgia, and Spurdle, Amanda
- Abstract
BRCA1 is involved in numerous essential processes in the cell, and the effects of BRCA1 dysfunction in breast cancer carcinogenesis are well described. Many of the breast cancer susceptibility genes such as BRCA2, p53, ATM, CHEK2, and BRIP1encode proteins that interact with BRCA1. BCL6 corepressor-like 1 (BCoR-L1) is a newly described BRCA1-interacting protein that displays high homology to several proteins known to be involved in the fundamental processes of DNA damage repair and transcription regulation. BCoR-L1 has been shown to play a role in transcription corepression, and expression of the X-linked BCoR-L1gene has been reported to be dysregulated in breast cancer subjects. BCoR-L1is located on the X chromosome and is subject to X inactivation. We performed mutation analysis of 38 BRCA1/2mutation-negative breast cancer families with male breast cancer, prostate cancer, and/or haplotype sharing around BCoR-L1to determine whether there is a role for BCoR-L1as a high-risk breast cancer predisposition gene. In addition, we conducted quantitative real-time PCR (qRT-PCR) on lymphoblastoid cell lines (LCLs) from the index cases from these families and a number of cancer cell lines to assess the role of BCoR-L1dysregulation in cancer and cancer families. Very little variation was detected in the coding region, and qRT-PCR analysis revealed that BCoR-L1expression is highly variable in cancer-free subjects, high-risk breast cancer patients, and cancer cell lines. We also report the investigation of a new expression control, DIDO1(death inducer-obliterator 1), that is superior to GAPDH(glyceraldehyde-3-phosphate dehydrogenase) and UBC(ubiquitin C) for analysis of expression in LCLs. Our results suggest that BCoR-L1expression does not play a large role in predisposition to familial breast cancer.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.